Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-07

Clinical Trial Update: Healthy Volunteer Study Using 3 Different Formulations of Firategrast [Phase 1]

View source ↗

Summary

Phase 1 healthy volunteer study evaluating three formulations of Firategrast; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Firategrast (Firategrast)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 1 | Status: COMPLETED